^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MTI-31

    i
    Company:
    Fudan University, Luoxin Pharma, Shanghai Inst. of Materia Medica
    Drug class:
    mTORC1 inhibitor, mTORC2 inhibitor
    Related drugs:
    Apply
    A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors (NCT03125746)
    Phase 1
    Shandong Luoxin Pharmaceutical Group Stock Co.,...
    Recruiting
    Last update posted :
    01/05/2021
    Initiation :
    06/12/2017
    Primary completion :
    10/28/2021
    Completion :
    10/28/2021
    HER-2 • ER
    |
    HER-2 negative
    |
    exemestane • MTI-31